Mobile Site ›
Print Friendly View

Test ID: OPRM1    
Opioid Receptor, Mu 1 (OPRM1) Genotype for Naltrexone Efficacy

Secondary ID A test code used for billing and in test definitions created prior to November 2011

89612

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Identifying individuals with a higher probability of successful treatment for alcoholism with naltrexone

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

 

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) 5'-Nuclease End point Allelic Discrimination Analysis

(PCR is utilized pursuant to a license agreement with Roche Molecular System, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

OPRM1 Genotype, Naltrexone Efficacy

Aliases Lists additional common names for a test, as an aid in searching

Acamprosate Calcium (CAMPRAL)
CAMPRAL (Acamprosate Calcium)
MOR
Mu-Opioid Receptor (OPRM1)
Naltrexone
Opioid mu Receptor
OPRM1 (mu-Opioid Receptor)